MarketCap
Facebook
X
Telegram
Oyster Point Pharma P/S Ratio | OYST
Annual P/S Ratio Oyster Point Pharma
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 12.7 | - | - | - | - | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.7 | 12.7 | 12.7 |
P/S Ratio of other stocks in the Biotechnology industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Forward Pharma A/S
FWP
|
7.83 | - | -0.75 % | $ 18.7 M |  Danmark |
 |
Orchard Therapeutics plc
ORTX
|
29.7 | - | 1.02 % | $ 90.8 M |  Britain |
 |
La Jolla Pharmaceutical Company
LJPC
|
1.68 | - | - | $ 154 M |  USA |
 |
Nabriva Therapeutics plc
NBRV
|
0.111 | - | - | $ 4.55 M |  Irlanda |
 |
Intercept Pharmaceuticals
ICPT
|
9.15 | - | - | $ 643 M | USA |
 |
NGM Biopharmaceuticals
NGM
|
28.8 | - | - | $ 127 M | USA |
 |
Regulus Therapeutics
RGLS
|
4.86 | - | - | $ 155 M | USA |
 |
9 Meters Biopharma
NMTR
|
38.5 | - | -42.97 % | $ 1.05 M | USA |
 |
Chinook Therapeutics
KDNY
|
227 | - | - | $ 2.6 B | USA |
 |
Lumos Pharma
LUMO
|
12 | - | - | $ 35.3 M | USA |
 |
Syros Pharmaceuticals
SYRS
|
16.6 | - | -8.44 % | $ 3.4 M | USA |
 |
Citius Pharmaceuticals
CTXR
|
1.82 K | $ 0.45 | 13.31 % | $ 4.98 M | USA |
 |
Aravive
ARAV
|
6.61 | - | -13.39 % | $ 1.45 M | USA |
 |
Novo Nordisk A/S
NVO
|
0.708 | $ 39.12 | 0.17 % | $ 174 B | Danmark |
 |
Abeona Therapeutics
ABEO
|
43.3 | $ 4.33 | -1.7 % | $ 229 M | USA |
 |
AIM ImmunoTech
AIM
|
12.9 | $ 0.16 | 3.97 % | $ 259 K | USA |
 |
Akebia Therapeutics
AKBA
|
1.42 | $ 0.63 | 11.85 % | $ 162 M | USA |
 |
Alnylam Pharmaceuticals
ALNY
|
11 | $ 228.15 | 1.84 % | $ 29.9 B | USA |
 |
Altimmune
ALT
|
7.76 K | $ 2.04 | -3.77 % | $ 180 M | USA |
 |
Assembly Biosciences
ASMB
|
4.27 | $ 19.65 | -0.96 % | $ 220 M | USA |
 |
Ascendis Pharma A/S
ASND
|
18.2 | $ 245.48 | 0.87 % | $ 14.9 B | Danmark |
 |
Beam Therapeutics
BEAM
|
22.9 | $ 23.79 | -1.08 % | $ 2.35 B | USA |
 |
Benitec Biopharma
BNTC
|
54.5 | $ 8.58 | -0.81 % | $ 399 M | USA |
 |
Capricor Therapeutics
CAPR
|
49.3 | $ 5.72 | -3.54 % | $ 266 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Cerus Corporation
CERS
|
2.12 | $ 2.37 | 1.5 % | $ 452 M | USA |
 |
Cullinan Management
CGEM
|
35.1 | $ 14.55 | 1.25 % | $ 877 M | USA |
 |
Curis
CRIS
|
1 | $ 0.38 | -2.33 % | $ 5 M | USA |
 |
CorMedix
CRMD
|
0.00146 | $ 7.95 | 1.27 % | $ 573 K | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 14.37 | 3.53 % | $ 929 M | USA |
 |
CEL-SCI Corporation
CVM
|
366 | $ 1.6 | -1.84 % | $ 12.8 M | USA |
 |
Cytokinetics, Incorporated
CYTK
|
0.0857 | $ 60.7 | -0.87 % | $ 7.29 M | USA |
 |
Daré Bioscience
DARE
|
16.4 | $ 0.64 | -0.33 % | $ 7.15 M | USA |
 |
DBV Technologies S.A.
DBVT
|
500 | $ 9.97 | 2.21 % | $ 1.39 B |  France |
 |
Denali Therapeutics
DNLI
|
7.68 | $ 18.66 | 1.35 % | $ 3.22 B | USA |
 |
Precision BioSciences
DTIL
|
1.89 | $ 6.4 | -3.61 % | $ 82.1 M | USA |
 |
Dyadic International
DYAI
|
10.2 | $ 0.43 | 7.72 % | $ 15.6 M | USA |
 |
Enanta Pharmaceuticals
ENTA
|
0.00397 | $ 12.0 | 3.09 % | $ 256 K | USA |
 |
Entera Bio Ltd.
ENTX
|
2.13 K | $ 2.83 | -3.25 % | $ 131 M |  Israel |
|
Forte Biosciences
FBRX
|
181 | $ 76.99 | 0.03 % | $ 997 M | USA |
 |
Exelixis
EXEL
|
5.05 | $ 65.14 | 0.95 % | $ 17.7 B | USA |